Search

Search Constraints

You searched for: Author/Creator Bahary, Nathan

Search Results

22. Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer. Issue 4 (16th August 2013)

23. Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age. (5th June 2018)

24. Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma. Issue 3 (24th April 2021)

25. Smad4 Loss in Esophageal Adenocarcinoma Is Associated With an Increased Propensity for Disease Recurrence and Poor Survival. (April 2015)

26. Smad4 Loss in Esophageal Adenocarcinoma Is Associated With an Increased Propensity for Disease Recurrence and Poor Survival. (April 2015)

27. SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma. Issue 5 (18th May 2021)

29. The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patients. Issue 3 (March 2023)